Correlation Between Biotechnology Ultrasector and Goldman Sachs

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Goldman Sachs Technology, you can compare the effects of market volatilities on Biotechnology Ultrasector and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Goldman Sachs.

Diversification Opportunities for Biotechnology Ultrasector and Goldman Sachs

0.01

Correlation Coefficient

Biotechnology Ultrasector  Goldman Sachs

Significant diversification

The 3 months correlation between Biotechnology and Goldman is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Goldman Sachs Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Technology and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Technology has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Goldman Sachs go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Goldman Sachs

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Goldman Sachs. In addition to that, Biotechnology Ultrasector is 2.4 times more volatile than Goldman Sachs Technology. It trades about -0.18 of its total potential returns per unit of risk. Goldman Sachs Technology is currently generating about -0.01 per unit of volatility. If you would invest  2,893  in Goldman Sachs Technology on November 29, 2024 and sell it today you would lose (60.00) from holding Goldman Sachs Technology or give up 2.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Goldman Sachs Technology

Biotechnology Ultrasector

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Goldman Sachs Technology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Goldman Sachs Technology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Goldman Sachs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Ultrasector and Goldman Sachs

The main advantage of trading using opposite Biotechnology Ultrasector and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.

The idea behind Biotechnology Ultrasector Profund and Goldman Sachs Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.